United States· US:83804-002_34ab96b8-aed9-14da-e063-6294a90a5667
SEFUDUN NAIL FUNGUS TREATMENT
A medicinal product containing ginger, registered in United States by Shenzhen Shandian Jingling Technology Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GINGER
- Manufacturer
- Shenzhen Shandian Jingling Technology Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1183804-002-01
- ndc11838040020160 mL in 1 BOTTLE (83804-002-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ginger in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBioCare Glucosamine MSM Complex tabletsBioCare Ltd
- SwitzerlandZintona, HartkapselnMIT Gesundheit Swiss GmbH
- GermanyIngwerwurzelstock (Pulver) GrünwalderGrünwalder Gesundheitsprodukte Gmbh
- PolandLokomotivaAflofarm Farmacja Polska Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Tradimed Ingwer Rheuma
- Germany · Ingwerwurzelstock (Pulver) Grünwalder
- Netherlands · Tradimed
- Poland · Lokomotiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3acb086-f97d-441e-9c4d-11acbd6c5a10 GET /v1/drugs/c3acb086-f97d-441e-9c4d-11acbd6c5a10?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "30",
"substance": "GINGER",
"productndc": "83804-002",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "g/60mL",
"application_number": "505G(a)(3)",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about ginger.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.